Retrospective Study
Copyright ©The Author(s) 2025.
World J Diabetes. Jul 15, 2025; 16(7): 104970
Published online Jul 15, 2025. doi: 10.4239/wjd.v16.i7.104970
Table 4 Comparison of clinical data between recurrence and non-recurrence groups

Recurrence group (n = 40)
Non-recurrence group (n = 163)
χ2/t
P value
Gender0.7740.379
    Male2277
    Female1886
Age46.93 ± 7.7844.32 ± 10.161.5160.131
Body mass index (kg/m2)23.39 ± 2.3423.41 ± 2.200.0520.958
Course of diabetes (year)6.57 ± 0.316.46 ± 0.471.3370.183
Preoperative glycated hemoglobin level (%)8.62 ± 1.758.37 ± 0.891.2680.206
Fasting blood glucose level (mmol/L)11.05 ± 1.878.22 ± 0.6715.73< 0.0001
Smoking history8.9880.003
    With2871
    Without1292
Alcohol consumption history0.0290.866
    With2188
    Without1975
Lund-Mackay score18.15 ± 3.5310.02 ± 3.3413.65< 0.0001
VAS-measured nasal symptom severity score6.95 ± 0.855.11 ± 0.6614.94< 0.0001
Surgery site0.0650.799
    Left2286
    Right1877
Operation time (min)61.48 ± 5.8962.72 ± 7.440.9790.329
Intraoperative blood loss (mL)46.40 ± 4.9847.31 ± 5.320.9840.326
Nasal septum deviation7.0860.008
    With2980
    Without1183
Allergic rhinitis5.5880.018
    With2568
    Without1595
Bronchial asthma8.7830.003
    With2249
    Without18114
Middle turbinectomy0.4470.504
    With1656
    Without24107
Postoperative infection10.4810.001
    With1730
    Without23133
Long-term use of nasal decongestants5.5800.018
    With2672
    Without1491
Anxiety1.6970.193
    With2375
    Without1788
Compliance with medical prescriptions13.9610.0002
    With15113
    Without2550